ARCHIVES

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

March 21, 2003

Arthur Upton New Name In Director Race; Califano Meets With Prospects

May 6, 1977

Therapeutic Vaccine May Fight Pancreatic Cancer

February 23, 2007

HCFA Sees Applications For DRGs And Research

September 27, 1985

Case Study: The Post-Surgical Treatment Of A Child With Medulloblastoma At The Burzynski Clinic

September 25, 1998

Zaltrap Shows Improvement in Survival In Stage IV Metastatic Colorectal Cancer

July 29, 2011